Evolent Health (NYSE:EVH) Earns “Outperform” Rating from Royal Bank of Canada

Royal Bank of Canada restated their outperform rating on shares of Evolent Health (NYSE:EVH – Free Report) in a research report report published on Monday morning, Benzinga reports. Royal Bank of Canada currently has a $42.00 target price on the technology company’s stock. EVH has been the topic of a number of other reports. JPMorgan […]

Leave a Reply

Your email address will not be published.

Previous post Vertex Energy (NASDAQ:VTNR) Research Coverage Started at StockNews.com
Next post MicroAlgo (NASDAQ:MLGO) and Thoughtworks (NASDAQ:TWKS) Head to Head Analysis